سرطان المثانة العضلي الغازي الذي لم يحقق استجابة كاملة بعد العلاج الثلاثي

References

• Trimodality therapy is best suited for patients with solitary, unifocal cT2-T3a tumours, absence of extensive or multifocal CIS, no or unilateral hydronephrosis, and good baseline bladder function.
• Trimodality therapy should also be considered for patients medically unfit or unwilling to undergo RC.
• Offer salvage cystectomy to patients with muscle-invasive bladder cancer recurrence after trimodality therapy.
• In contemporary series, salvage cystectomy is required in approximately 10-15% of patients treated with TMT due to invasive in-bladder recurrences and can be curative.